lu 135252 has been researched along with Kidney Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barton, M | 1 |
| Dieterich, M; Kossmehl, P; Kreutz, R; Rothermund, L; Traupe, T; Yagil, C; Yagil, Y | 1 |
| Amann, K; Odoni, G; Orth, SR; Raschack, M; Ritz, E; Strzelczyk, P | 1 |
| Back, WE; Braun, C; Conzelmann, T; Kirchengast, M; Rohmeiss, P; Schaub, M; Schnülle, P; Tullius, SG; van der Woude, FJ; Vetter, S; Yard, B | 1 |
1 review(s) available for lu 135252 and Kidney Diseases
| Article | Year |
|---|---|
Endothelin antagonism and reversal of proteinuric renal disease in humans.
Topics: Endothelins; Humans; Isoxazoles; Kidney Diseases; Phenylpropionates; Proteinuria; Pyridines; Pyrimidines; Receptor, Endothelin A; Thiophenes | 2011 |
3 other study(ies) available for lu 135252 and Kidney Diseases
| Article | Year |
|---|---|
Nephroprotective effects of the endothelin ET(A) receptor antagonist darusentan in salt-sensitive genetic hypertension.
Topics: Albuminuria; Animals; Body Weight; Desoxycorticosterone; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin-1; Hypertension; Kidney; Kidney Diseases; Male; Organ Size; Osteopontin; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred Strains; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Sialoglycoproteins; Sodium; Sodium Chloride, Dietary | 2003 |
The ET(A) receptor blocker LU 135252 prevents chronic transplant nephropathy in the "Fisher to Lewis" model.
Topics: Animals; Blood Pressure; Endothelin Receptor Antagonists; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Male; Organ Size; Phenylpropionates; Postoperative Complications; Pyrimidines; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptor, Endothelin A; Survival Analysis | 1999 |
Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist.
Topics: Administration, Oral; Animals; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Graft Rejection; Graft Survival; Kidney Diseases; Kidney Glomerulus; Kidney Transplantation; Male; Phenylpropionates; Pyrimidines; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptor, Endothelin A; Receptors, Endothelin; RNA, Messenger | 1999 |